Cadonilimab plus chemotherapy, with or without bevacizumab, could be a safe and effective treatment option, according to researchers.

Researchers found no significant differences in the risk of overall adverse events (AEs), but there were significant differences in grade 3 or higher AEs, serious AEs, treatment discontinuations due ...

Investigators explored the role of treatment intensification with androgen receptor pathway inhibitors in patients with high-risk localized prostate cancer.

Researchers sought to determine trends in participation and detection of CRC in multiround FIT-based CRC screening.

Integrating secure chat technology was shown to be an innovative way to facilitate urgent oncology admissions and significantly reduce delays in communication.

HealthDay News — Newly diagnosed pancreatic cancer patients receiving palliative care (PC) consultations have an increased prevalence of anxiety and depression, according to a study recently published ...

Researchers sought to determine whether cilta-cel would have similar results in a real-world RRMM population as in a clinical trial population.

Researchers sought to determine which genomic imbalances may help with risk stratification in patients with newly-diagnosed T-ALL.

From 2000 to 2019, definitive treatment for those with intermediate- or high-risk disease and limited life expectancy increased.

Authors recommend patient and physician education and changes to practice guidelines and payment to overcome barriers to palliative care use.

In a post hoc analysis of the phase 3 VISION trial, investigators analyzed PSA decline and clinical and patient-reported outcomes in patients with mCRPC receiving 177Lu-PSMA-617.

In the wake of Donald Trump's victory in the presidential election, retailers report that online sales of emergency contraceptives have soared.